Healthy Returns: FDA chief Marty Makary on compounded GLP-1s, vaccines and China

Makary helms the FDA in the midst of a contentious stretch for the agency, defined by massive staff and budget cuts and sweeping changes to vaccine policy.  

Leave a Reply

Your email address will not be published. Required fields are marked *

Sign Up For Real Ac.